title: CETP inhibition shows promise as way to reduce cardiovascular disease risk.
authors.forename: Mike
authors.initials: M
authors.lastname: Mitka
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D008078:Cholesterol, LDL / Q000097:blood / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000517:prevention & control; D009204:Myocardial Revascularization; D023303:Oxazolidinones / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012306:Risk
chemical_list: D053480:Cholesterol Ester Transfer Proteins; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D023303:Oxazolidinones; C530884:anacetrapib